oxytocin in cesarean-sections. what's new?
Clicks: 169
ID: 157816
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
30.0
/100
169 views
25 readers
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #118 of 139 articles by views in methods in molecular biology (clifton, nj)
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 139 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Oxytocin is the uterotonic agent of choice in the prevention and treatment of postpartum uterine atony. Nevertheless, there is no consensus on the optimal dose and rate for use in cesarean sections. The use of high bolus doses (e.g., 10 IU of oxytocin) can determine deleterious cardiovascular changes for the patient, especially in situations of hypovolemia or low cardiac reserve. Furthermore, high doses of oxytocin for prolonged periods may lead to desensitization of oxytocin receptors in myometrium, resulting in clinical inefficiency.
| Reference Key |
yamaguchirevistaoxytocin
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Eduardo Tsuyoshi Yamaguchi;Mônica Maria Siaulys;Marcelo Luis Abramides Torres |
| Journal | methods in molecular biology (clifton, nj) |
| Year | Year not found |
| DOI |
10.1016/j.bjane.2014.11.015
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.